Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7

Pharmazie

Volumn 68, Issue 12, 2013, Pages 945-950

  Liu, Xin ^a   Huang, Ting ^b   Chen, Jian Xing ^b   Zeng, Jia ^b   Fan, Xu Ran ^c   Xu Zhu, ^c   Yu, Zhen Wen ^c   Sun, Xiao Yu ^c   Hong, Mo ^c   Sun, Hong Zhi ^a  

^a Joint Center for Translational Medicine   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^c JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARBIDOL; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B7; HYMECROMONE; PROPOFOL; ZIDOVUDINE;

AREA UNDER THE CURVE; ARTICLE; COMPETITIVE INHIBITION; GLUCURONIDATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MAXIMUM PLASMA CONCENTRATION;

ANESTHETICS, INTRAVENOUS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; AREA UNDER CURVE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INDICATORS AND REAGENTS; INDOLES; KINETICS; PROPOFOL; ZIDOVUDINE;

EID: 84892777879     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2641     Document Type: Article

References (27)

1. Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW, Belanger A(2000) 3′-Azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 28: 497-502.
2. Bernard O, Guillemette C (2004) The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32: 775-778.
3. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299: 998-1006.
4. Dong PP, Fang ZZ, Zhang YY, Ge GB, Mao YX, Zhu LL, Qu YQ, Li W, Wang LM, Liu CX, Yang L (2011) Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib. Acta Pharmacol Sin 32: 399-407.
5. Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY (2012) Investigation of UDP-glucuronosyltransferases (UGT) inhibitory properties of carvacrol. Phytother Res 26: 86-90.
6. Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L (2010) Timedependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69: 193-199.
7. Fang ZZ, Zhang YY,Wang XL, Cao YF, Huo H, Yang L (2011a) Bioactivation of herbal constituents: simple alerts in the complex system. Expert Opin Drug Metab Toxicol 7: 989-1007.
8. Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L (2011b) Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interaction. Phytother Res 25: 256-263.
9. Huang T, Fang ZZ, Yang L (2010) Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions. Pharmazie 65: 919-921.
10. Huang T, Fang ZZ, Zhang YY, Zhu LL, Feng LL, Zheng W, Cao YF, Sun DX, Yang L (2011) Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucurosyltransferases in human liver. Pharmazie 66: 212-215.
11. Jin XL, Tang SH, Fang ZZ, Qu YQ, Liang R, Gao ZM, Tang B, Sun DG, Li M, Yang L, Wang LM (2011) Reversible and time-dependent inhibition of CYP3A4-mediated nifedipine oxidation by noscapine. Lat Am J Pharm 30: 1854-1857.
12. Kiang TK, Ensom MH, Chang TK (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106: 97-132.
13. King CD, Tang W, Ngui J, Tephly T, Brau M (2001) Characterization of rat and human UDP-glucuronyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61: 49-53.
14. Liang SC, Ge GB, Liu HX, Shang HT, Wei H, Fang ZZ, Zhu LL, Mao YX, Yang L (2011) Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI- MS. J Pharm Biomed Anal 54: 236-241.
15. Lin JH, Lu AYH (1997) Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49: 403-449.
16. Liu MY, Wang S, Yao WF, Wu HZ, Meng SN, Wei MJ (2009) Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers. Clin Ther 31: 784-792.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
18. Miners JO, Mackenzie PI (1991) Drug glucuronidation in human. Pharmacol Ther 51: 347-369.
19. Pecheu EJ, Lavllette D, Alcaras F, Molle J, Boriskin YS, Roberts M, Cosset FL, Polyak SJ (2007) Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol. Biochemistry 46: 6050-6059.
20. Qu YQ, Fang ZZ, Yang L, Zhu LL, Dong PP, Gao ZM, Liang R, Zhang YY, Ge GB, Wang LM (2011) Reversible inhibition of four important human liver cytochrome P 450 enzymes by diethylstilbestrol. Pharmazie 66: 216-221.
21. Ritter JK (2000) Roles of glucuronidation and UDP-glucuronosyl- transferases in xenobiotic bioactivation reactions. Chem Biol Interact 129: 171-193.
22. Sahai J, Gallicano K, Pakuts A, Cameron DW (1994) Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. J Infect Dis 169: 1103-1107.
23. Soars MG, Ring BJ, Wrighton SA (2003) The effect of incubation conditions on the enzyme kinetics of UDP-glucuronyltransferases. Drug Metab Dispos 31: 762-767.
24. Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J (2010a) Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24: 1213-1216.
25. Sun DX, Lu CJ, Fang ZZ, Zhang YY, Cao YF, Mao YX, Zhu LL, Yin J, Yang L (2010b) Reversible inhibition of three important human liver cytochrome P450 enzymes by tiliroside. Phytother Res 24: 1670-1675.
26. Taburet AM, Singlas E (1996) Drug interactions with antiviral drugs. Clin Pharmacokinet 30: 385-401.
27. Zhong Q, Yang ZQ, Liu YY, Deng H, Xiao H, Shi L, He J (2009) Antiviral activity of arbidol against coxsackie virus B5 in vitro and in vivo. Arch Virol 154: 601-607.